Nabriva Therapeutics PLC (NASDAQ:NBRV)

0.1821
Delayed Data
As of Aug 09
 -0.0069 / -3.65%
Today’s Change
0.16
Today|||52-Week Range
1.40
-69.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues847.0K461.0K797.0K1.7M
 
 
 
 
 
Depreciation And Amortization129.0K129.0K119.0K234.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses18.4M21.3M31.4M20.7M
 
 
 
 
 
Research And Development9.7M8.9M21.4M7.5M
 
 
 
 
 
Total Operating Expenses18.6M21.5M31.6M20.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.7M-21.0M-30.8M-19.2M
 
 
 
 
 
Extraordinary Charge0.00-31.9M-118.0K0.00
 
 
 
Interest Expense On Debt7.0K8.0K114.0K899.0K
 
 
 
 
 
Other Expenses-141.0K-54.0K-100.0K70.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.8M-53.0M-31.1M-20.1M
 
 
 
 
 
Income Taxes-48.0K-151.0K-258.0K-154.0K
 
 
 
 
 
Net Income-17.8M-52.8M-30.8M-20.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.5M58.4M67.0M68.7M
 
 
 
 
 
Shares To Calculate EPS Diluted40.5M58.4M67.0M68.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.44-$0.90-$0.41-$0.29
 
 
 
 
 
EPS Diluted-$0.44-$0.90-$0.46-$0.29